FDA Drug recall D-1142-2017
ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg)…
- FDA Drug
- Class I
- terminated
- Published 2017-09-20
On 2017-09-20 the FDA classified a Class I recall of ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg)… by Andropharm, citing marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1142-2017 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2017-06-06 |
| Published | 2017-09-20 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Andropharm |
| Distribution | FL |
Product
ANDROPHARM STEN Z (2, 17a-Dimethyl-17b-hydroxy-5a-androst-1-en-3-one 10mg and 17b-hydroxy-2a, 17b-dimethyl-5a-androstan-3-one azine 10 mg) capsule, packaged in 60-count bottle, Andropharm.com, UPC: 6 42125 50294 8
Reason
Marketed without an approved NDA/ANDA: product label states it contains anabolic steroids.
Identifiers
| upc | 642125502948 |
|---|---|
| code_info | All lots remaining within expiry. |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1142-2017%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.